EMA Agrees Monovalent XBB Vaccines Best For Coming COVID-19 Campaigns

The European Medicines Agency says it is talking with international partners and pharmaceutical companies about the epidemiological situation with SARS-CoV-2 and how authorized COVID-19 vaccines can best be adapted to emerging variants.